Citation: | ZHANG Qiao, ZHOU Xuezhi, CHEN Binghe, HOU Dong, WU Xinjun, ZHU Shaohui. A two-sample Mendelian randomization study of type 2 diabetes mellitus and colorectal cancer risk[J]. Chinese Journal of General Practice, 2024, 22(9): 1471-1474. doi: 10.16766/j.cnki.issn.1674-4152.003661 |
[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. doi: 10.3322/caac.21660
|
[2] |
FENG R M, SU Q L, HUANG X Y, et al. Cancer situation in China: what does the China cancer map indicate from the first national death survey to the latest cancer registration?[J]. Cancer Commun, 2023, 43(1): 75-86. doi: 10.1002/cac2.12393
|
[3] |
PIGEYRE M, GERSTEIN H, AHLQVIST E, et al. Identifying blood biomarkers for type 2 diabetes subtyping: a report from the origin trial[J]. Diabetologia, 2023, 66(6): 1045-1051. doi: 10.1007/s00125-023-05887-7
|
[4] |
刘瑜婷, 石敏, 陈燕娜, 等. 血清C1q/肿瘤坏死因子相关蛋白9水平与妊娠期糖尿病及其胰岛素抵抗的关系[J]. 中华全科医学, 2024, 22(2): 195-197, 229. doi: 10.16766/j.cnki.issn.1674-4152.003363
LIU Y T, SHI M, CHEN Y N, et al. Serum levels of C1q/TNF-related protein 9 and its association with insulin resistance in gestational diabetes mellitus[J]. Chinese Journal of General Practice, 2024, 22(2): 195-197, 229. doi: 10.16766/j.cnki.issn.1674-4152.003363
|
[5] |
LIU X Q, LI D C, GAO W X, et al. Identification of the shared gene signature and biological mechanism between type 2 diabetes and colorectal cancer[J]. Front Genet, 2023;14: 1202849. DOI: 10.3389/fgene.2023.1202849.
|
[6] |
LI P S, WANG H Y, GUO L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study[J]. BMC Med, 2022, 20(1): 443. DOI: 10.1186/s12916-022-02657-x.
|
[7] |
BIRNEY E. Mendelian randomization[J]. Cold Spring Harb Perspect Med, 2022, 12(4): a041302. DOI: 10.1101/cshperspect.a041302.
|
[8] |
MUKAMAL K J, STAMPFER M J, RIMM E B. Genetic instrumental variable analysis: time to call mendelian randomization what it is. The example of alcohol and cardiovascular disease[J]. Eur J Epidemiol, 2020, 35(2): 93-97. doi: 10.1007/s10654-019-00578-3
|
[9] |
XUE H R, WU C, PAN W. Leveraging existing GWAS summary data of genetically correlated and uncorrelated traits to improve power for a new GWAS[J]. Genet Epidemiol, 2020, 44(7): 717-732. doi: 10.1002/gepi.22333
|
[10] |
CARTER A R, SANDERSON E, HAMMERTON G, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation[J]. Eur J Epidemiol, 2021, 36(5): 465-478. doi: 10.1007/s10654-021-00757-1
|
[11] |
CHEN X, KONG J Q, DIAO X Y, et al. Depression and prostate cancer risk: a Mendelian randomization study[J]. Cancer Med, 2020, 9(23): 9160-9167. doi: 10.1002/cam4.3493
|
[12] |
YANG Y, XIAN W, WU D D, et al. The role of obesity, type 2 diabetes, and metabolic factors in gout: a Mendelian randomization study[J]. Front Endocrinol (Lausanne), 2022, 13: 917056. DOI: 10.3389/fendo.2022.917056.
|
[13] |
陈继鑫, 周沁心, 郭天赐, 等. 白细胞介素-1受体拮抗剂与骨关节炎及亚型的孟德尔随机化研究[J]. 医学研究杂志, 2024, 53(4): 46-51.
CHEN J X, ZHOU Q X, GUO T C, et al. Mendelian Randomization Study of Interleukin-1 Receptor Antagonists and Osteoarthritis and Subtypes[J]. Journal of Medical Research, 2024, 53(4): 46-51.
|
[14] |
LUO G, YAO Y Y, TAO J C, et al. Causal association of sleep disturbances and low back pain: a bidirectional two-sample Mendelian randomization study[J]. Front Neurosci, 2022, 16: 1074605. DOI: 10.3389/fnins.2022.1074605.
|
[15] |
LIN Z T, PAN I, PAN W. A practical problem with Egger regression in Mendelian randomization[J]. PLoS Genet, 2022, 18(5): e1010166. DOI: 10.1371/journal.pgen.1010166.
|
[16] |
XU J W, ZHANG S Y, TIAN Y, et al. Genetic causal association between iron status and osteoarthritis: a two-sample Mendelian randomization[J]. Nutrients, 2022, 14(18): 3683-3696. doi: 10.3390/nu14183683
|
[17] |
GOTO A, YAMAJI T, SAWADA N, et al. Diabetes and cancer risk: a Mendelian randomization study[J]. Int J Cancer, 2020, 146(3): 712-719. doi: 10.1002/ijc.32310
|
[18] |
YUAN S, KAR S, CARTER P, et al. Is Type 2 diabetes causally associated with cancer risk? Evidence from a two-sample Mendelian randomization study[J]. Diabetes, 2020, 69(7): 1588-1596. doi: 10.2337/db20-0084
|
[19] |
MURPHY N, SONG M Y, PAPADIMITRIOU N, et al. Associations between glycemic traits and colorectal cancer: a Mendelian randomization analysis[J]. J Natl Cancer Inst, 2022, 114(5): 740-752. doi: 10.1093/jnci/djac011
|
[20] |
MAO X H, TAN J T, MAK L Y, et al. Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study[J]. Gut, 2024. DOI: 10.1136/gutjnl-2023-331701.
|
[21] |
MAGHLAPERIDZE Z, KAPETIVADZE V, TABUKASHVILI R, et al. The role of insulin-like growth factor-1 and insulin in development of colorectal cancer[J]. Georgian Med News, 2021(315): 26-29.
|
[22] |
CHEN H D, LIU L, LU M, et al. Implications of lifestyle factors and polygenic risk score for absolute risk prediction of colorectal neoplasm and risk-adapted screening[J]. Front Mol Biosci, 2021, 8: 685410. DOI: 10.3389/fmolb.2021.685410.
|